Diabetic retinopathy is a complication of diabetes that affects the eyes. It is caused by damage to the blood vessels of the light sensitive tissue at the back of the eye.
This system assists in the early diagnosis and treatment of patients with diabetic retinopathy. A patient after taking pupil dilation eye drops is positioned in front of a camera which images the retina. The images taken from the retina are then transmitted across the NHS network to remote ophthalmologists who perform the diagnosis. Messages from the remote ophthalmologists are then transmitted to the patient’s GP and a prompt care plan can be determined.
This technology enables more patients to be screened as the operator of the equipment need not be a trained ophthalmologist and mobile screening to remote and rural areas is feasible.
Developing our customer’s solution as one of the lead developers working for the National Screening Programme for Diabetic Retinopathy; we took overall technical lead and responsibility for the redevelopment of an existing diabetic retinopathy solution to incorporate HL7v3 messaging as part of the National Programme for IT.
Working directly with the other three accredited suppliers to develop the HL7v3 messages, we provided sole technical authority on behalf of our client, management of all NHS client expectations and providing expert knowledge of systems integration and HL7 messaging to the other suppliers throughout the duration of compliance testing, technical audit and review. Migrated existing client data and business rules to become compatible with the new SNOMED codes.
Subcontracted by Clinisys Group.